In this case, the tumor’s morphological features, positive immunohistochemical staining for progesterone receptor (PR) and carcinoembryonic antigen (CEA), and negative estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) are characteristic. This evidence concerns the gene PGR and neoplasm.